{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 434002897
| IUPAC_name = [2-[(8''S'',9''S'',10''R'',11''S'',13''S'',14''S'',17''R'')-11,17-Dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6''H''-cyclopenta[''a'']phenanthren-17-yl]-2-oxoethyl] 4-[4-[bis(2-chloroethyl)amino]phenyl]butanoate
| image = Prednimustine.svg
| width = 250

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 29069-24-7
| ATC_prefix = L01
| ATC_suffix = AA08
| PubChem = 34457
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 9403SIO2S8
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = C19512
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 31708

<!--Chemical data-->
| C=35 | H=45 | Cl=2 | N=1 | O=6 
| molecular_weight = 646.64 g/mol
| SMILES = C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)CCCc4ccc(cc4)N(CCCl)CCCl)O)CCC5=CC(=O)C=C[C@]35C)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C35H45Cl2NO6/c1-33-14-12-26(39)20-24(33)8-11-27-28-13-15-35(43,34(28,2)21-29(40)32(27)33)30(41)22-44-31(42)5-3-4-23-6-9-25(10-7-23)38(18-16-36)19-17-37/h6-7,9-10,12,14,20,27-29,32,40,43H,3-5,8,11,13,15-19,21-22H2,1-2H3/t27-,28-,29-,32+,33-,34-,35-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = HFVNWDWLWUCIHC-GUPDPFMOSA-N
| synonyms = <small>11β,17α-dihydroxy-3,20-dioxopregna-1,4-dien-21-yl 4-<nowiki/>{4-[bis(2-chloroethyl)amino]phenyl}butanoate</small>
}}

'''Prednimustine''' is a drug used in [[chemotherapy]]. It is the [[ester]] formed from two other drugs, [[prednisolone]] and [[chlorambucil]]. It can be associated with [[myoclonus]].<ref name="pmid8998190">{{cite journal |vauthors=Monnerat C, Gander M, Leyvraz S |title=A rare case of prednimustine-induced myoclonus |journal=J. Natl. Cancer Inst. |volume=89 |issue=2 |pages=173–4 |date=January 1997 |pmid=8998190 |doi= 10.1093/jnci/89.2.173|url=http://jnci.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=8998190}}</ref>

==See also==
* [[Alestramustine]]
* [[Atrimustine]]
* [[Cortifen]]
* [[Estramustine phosphate]]
* [[Prednazate]]
* [[Prednazoline]]
* [[Sturamustine]]

==References==
{{Reflist|2}}

{{Chemotherapeutic agents}}
{{Glucocorticoids}}
{{Glucocorticoidics}}

[[Category:Alcohols]]
[[Category:Anilines]]
[[Category:Butyrates]]
[[Category:Corticosteroid esters]]
[[Category:Diketones]]
[[Category:Nitrogen mustards]]
[[Category:Organochlorides]]
[[Category:Corticosteroids]]

{{antineoplastic-drug-stub}}